Sign in

CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273181608
Phone
857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 8-K Event Executive or director change · Regulation FD disclosure
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. EFFECT Other Notice of Effectiveness
  5. 8-K/A Event Executive or director change · Shareholder vote results
  6. 4 Insider Changes in Ownership
  7. 144 Insider Sale of Securities
  8. 8-K Event Executive or director change · Shareholder vote results
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. S-3 Offering Registration Statement
  12. 10-Q Report Quarterly Report
  13. ARS Other Annual Report to Security Holders
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 41 · 818 filings